•  Blake Nissen

  A revamped strategic national stockpile still can’t match the pandemic’s latest surge

  The Strategic National Stockpile stores critical supplies. It fell short when the pandemic first hit. Now, a new effort is being implemented, but it’s still not providing what the U.S. needs.

  By Monika Evstatieva/NPR November 23, 2020 | 6:19 PM

•  Gene J. Puskar

  Kansas study finds mask mandates work to slow spread of coronavirus

  Researchers analyzed COVID-19 infection rates in Kansas following a statewide mask mandate. They found counties that chose to enforce it saw their cases decrease. Counties that chose to opt out saw cases continue to rise.

  By Jane Greenhalgh/NPR November 23, 2020 | 10:13 AM

•  Justin Tallis

  AstraZeneca coronavirus trial promises ‘highly effective’ new vaccine

  U.K.-based pharmaceutical company AstraZeneca has developed a vaccine that initial results show to be “highly effective in preventing” COVID-19, the company announced Monday.

  By Jaclyn Diaz/NPR November 23, 2020 | 7:58 AM

•  Matt Slocum

  How to sort through the uneasiness Thanksgiving brings this year

  Data shows that much of the current coronavirus surge is being caused by casual occasions like small gatherings — transmissions scientists say likely reflect people’s fatigue after so many months of social distancing.

  By Zoë Read/WHYY November 23, 2020 | 7:40 AM

•  Courtesy of Penn Highlands Healthcare

  Penn Highlands offers rapid COVID-19 testing in six rural locations

  Several counties that Penn Highlands serves, including Blair, Huntingdon and Elk, have seen higher incidence rates than the state average.

  By Min Xian/WPSU November 23, 2020 | 5:36 AM

•  Bebeto Matthews

  Inequality ‘baked into’ virus testing access as cases surge

  By Christine Fernando and Carolyn Thompson/The Associated Press November 22, 2020 | 3:04 PM

•  Susan Walsh

  FDA grants emergency authorization for a second COVID-19 antibody treatment

  In a clinical trial of about 800 people, the cocktail was shown to significantly reduce virus levels within days of treatment.

  By Matthew S. Schwartz/NPR November 22, 2020 | 2:45 PM

•  Fadel Dawood

  WHO trial finds remdesivir has ‘no meaningful effect’ in COVID-19 patients

  The medicine is one of the few to win regulatory approval as a treatment for the disease, but has fallen out of favor with the health authority.

  By Jason Beaubien/NPR November 20, 2020 | 4:19 PM

• With this Thanksgiving comes a sad first for many families: Lost loved ones

  For thousands in the United States, this Thanksgiving holiday will be the first without a loved one — as of Nov. 16, almost 250,000 Americans have died as a result of the virus.

  By Ximena Conde/WHYY November 20, 2020 | 1:49 PM

•  Justin Tallis

  Pfizer asks FDA to approve its COVID-19 vaccine for emergency use

  By Colin Dwyer/NPR November 20, 2020 | 1:24 PM

• White House urges vigilance on coronavirus but rejects lockdowns as solution

  “President Trump wanted me to make it clear that our task force, this administration and our president does not support another national lockdown. And we do not support closing schools,” Pence said — marking a position that has become a major point of disagreement between Democrats and Republicans.

  By Alana Wise/NPR November 20, 2020 | 7:52 AM

Load More